Genmab — September 2018
-
imponerende med den aktiebeholdning, når nu insiderkøb er totalt fraværende
-
JPMorgan European Pharma & Biotech Analyst Quigley hosts a conference call with CEO Van de Winkel on September 6 at 10 am.
https://thefly.com/landingPageNews.php?id=2785185 -
Servicemeddelelse: Jeg har Q&A med CEO Kaare Schulz fra Teva direkte fra USA på storskærm under Investordagen i København d. 18. september. Nærmere info følger med rabatkode til Proinvestors brugere.
-
New Ph2 trial: A Study of Tisotumab Vedotin for Patients With Platinum-Resistant Ovarian Cancer With a Safety Run-in of a Dose-Dense Regimen (innovaTV 208) https://www.clinicaltrials.gov/ct2/show/NCT03657043?term=NCT03657043&rank=1
-
De gør jeg med min bog som udkommer i september/oktober.
-
-
nice find. Seems they are even a bit behind with their press release, as clinicaltrials was set to 'active not recruiting' a month ago https://www.clinicaltrials.gov/ct2/history/NCT03298867?A=9&B=10&C=merged
-
God morgen
-
God morgen.
-
God morgen
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind